Mentor Capital Takes Investment Position in Each of 10 Cancer Immunotherapy Index Companies
1/19/2010 9:20:01 AM
More...
|
Northwest Biotherapeutics (NWBT) Announces Appointment of Robert A. Farmer to the Board of Directors
12/10/2009 8:30:31 AM
More...
|
Northwest Biotherapeutics (NWBT) Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
12/4/2009 9:15:25 AM
More...
|
Northwest Biotherapeutics (NWBT) Release: Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10/21/2009 9:16:23 AM
More...
|
Northwest Biotherapeutics (NWBT) Release: Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10/21/2009 7:47:58 AM
More...
|
Northwest Biotherapeutics (NWBT) Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
2/17/2009 10:18:36 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures $700,000 Equity Financing
2/10/2009 10:36:33 AM
More...
|
Northwest Biotherapeutics (NWBT) Settles Class Action Complaint, and SEC Investigation Closed Without Action
1/9/2009 7:58:31 AM
More...
|
Northwest Biotherapeutics (NWBT) Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer
12/29/2008 10:22:00 AM
More...
|
Northwest Biotherapeutics (NWBT) Secures US$0.5 Million Debt Financing
12/29/2008 9:36:09 AM
More...
|
|